Stoke Therapeutics Inc
NASDAQ:STOK

Watchlist Manager
Stoke Therapeutics Inc Logo
Stoke Therapeutics Inc
NASDAQ:STOK
Watchlist
Price: 31.96 USD 0.09% Market Closed
Market Cap: 1.8B USD

Intrinsic Value

The intrinsic value of one STOK stock under the Base Case scenario is 11.56 USD. Compared to the current market price of 31.96 USD, Stoke Therapeutics Inc is Overvalued by 64%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

STOK Intrinsic Value
11.56 USD
Overvaluation 64%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Stoke Therapeutics Inc

What is Valuation History?
Ask AI Assistant
What other research platforms think about STOK?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is STOK valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Stoke Therapeutics Inc.

Explain Valuation
Compare STOK to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about STOK?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Stoke Therapeutics Inc

Current Assets 272.4m
Cash & Short-Term Investments 248.3m
Receivables 10.8m
Other Current Assets 13.3m
Non-Current Assets 87.8m
Long-Term Investments 80.3m
PP&E 6.8m
Other Non-Current Assets 721k
Current Liabilities 41.7m
Accounts Payable 5.9m
Accrued Liabilities 29.3m
Other Current Liabilities 6.6m
Non-Current Liabilities 10.4m
Other Non-Current Liabilities 10.4m
Efficiency

Free Cash Flow Analysis
Stoke Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Stoke Therapeutics Inc

Revenue
205.6m USD
Operating Expenses
-178.8m USD
Operating Income
26.8m USD
Other Expenses
14.2m USD
Net Income
41m USD
Fundamental Scores

STOK Profitability Score
Profitability Due Diligence

Stoke Therapeutics Inc's profitability score is 43/100. The higher the profitability score, the more profitable the company is.

43/100
Profitability
Score

Stoke Therapeutics Inc's profitability score is 43/100. The higher the profitability score, the more profitable the company is.

STOK Solvency Score
Solvency Due Diligence

Stoke Therapeutics Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
81/100
Solvency
Score

Stoke Therapeutics Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

STOK Price Targets Summary
Stoke Therapeutics Inc

Wall Street analysts forecast STOK stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for STOK is 32.26 USD with a low forecast of 24.24 USD and a high forecast of 40.95 USD.

Lowest
Price Target
24.24 USD
24% Downside
Average
Price Target
32.26 USD
1% Upside
Highest
Price Target
40.95 USD
28% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Stoke Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for STOK is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

STOK Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one STOK stock?

The intrinsic value of one STOK stock under the Base Case scenario is 11.56 USD.

Is STOK stock undervalued or overvalued?

Compared to the current market price of 31.96 USD, Stoke Therapeutics Inc is Overvalued by 64%.

Back to Top